Venky's Expands AHP Capacity With ₹67 Cr Kesurdi Unit

VENKEYS S (INDIA): Venky's (India) Limited has commenced commercial production at its new manufacturing unit located at Kesurdi, Maharashtra, marking an important capacity expansion in its Animal Health Products (AHP) segment. The project involved an investment of approximately ₹67 crore and is aimed at strengthening the company's manufacturing capabilities in the animal healthcare business. The new facility has been developed to expand production capacity for specialised animal health products. With the commencement of commercial production, the company expects the additional manufacturing infrastructure to support volume growth of approximately 15–20% in the AHP segment. This expected growth reflects management's outlook following the expansion of the manufacturing facility. The ₹67 crore investment represents a significant development in the company's operational expansion plans. The new unit is expected to provide additional manufacturing capacity and support the company's ability to cater to demand for its animal health products. The AHP segment includes products serving the poultry healthcare market, making manufacturing capacity and product availability important aspects of its business operations. The anticipated 15–20% volume growth is a management expectation and should be viewed as forward-looking guidance rather than an already achieved result. Market participants may track capacity utilisation, production ramp-up and subsequent segment performance to assess the progress of the expansion. Overall, the commencement of commercial production at the Kesurdi manufacturing unit marks a key operational milestone for Venky's (India), supported by a project investment of ₹67 crore and an expected 15–20% volume growth in the AHP segment. This information is shared strictly as a corporate and market update for informational purposes and should not be considered investment advice, research analysis, or a recommendation to buy or sell any security.